enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases.
Envveno Medical stock last closed at $3.31, up 10.33% from the previous day, and has decreased 35.48% in one year. It has underperformed other stocks in the Medical Devices industry by 0.2 percentage points. Envveno Medical stock is currently +63.21% from its 52-week low of $2.03, and -48.92% from its 52-week high of $6.48.
As of May 1, 2025, there are 17.54M shares of NVNO outstanding. The market value of NVNO is $58.04M. In the last 24 hours, 108,725 NVNO shares were traded.
You need an online brokerage account in order to access the NASDAQ market and buy NVNO stock.
Based on our analysis, eToro is the best stock brokerage. eToro gives you:
Get $10 towards your purchase of stock by creating an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've selected the best brokerage, it's time to fill out some personal info so you are able to invest in NVNO today.
Now that you've finished signing up on the highest rated app to buy and sell stocks, your next step is to transfer the money for your investment:
Check out the tutorial below to see the process of transferring funds into your new investment account.
Once you have decided on the best place to buy Envveno Medical stock, it's crucial to evaluate their stock before you buy, so you truly wrap your head around the risk and opportunity.
WallStreetZen was created to help everyday investors perform more accurate fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on NVNO's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge NVNO's true value.
Using relative valuations methods:
You can access more valuation analysis on NVNO's stock here.
You can dive deeper into what analysts are projecting on the Envveno Medical stock forecast page.
Over the past year, insiders at NVNO have bought more shares than they have sold.
Francis Duhay, Director of NVNO, was the latest NVNO insider to buy. They bought $249,999.31 worth of NVNO stock on Dec 31, 2024.
Learn more about who owns NVNO shares here.
No, Envveno Medical doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other traders have to say.
You have two main options:
Click the Open button and your broker will place your order.
If you want more help investing in stocks on eToro, click the helpful video below:
Now that you own some NVNO shares, you'll want to stay up-to-date on your shares.
Add NVNO to a watchlist to track the latest developments regarding your NVNO stock.
To reiterate, here are the 6 steps to buy Envveno Medical stock:
If you are looking for a brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to get updates on your new investment in Envveno Medical, get started below.